Transmission of Pneumocystis carinii Disease from Immunocompetent Contacts of Infected Hosts to Susceptible HostsAlexis Dumoulin, Eduardo Dei‐Cas, El Moukhtar Aliouat et al.|European Journal of Clinical Microbiology & Infectious Diseases|2000Cited by 134
In Vitro Pharmacodynamic Parameters of Sordarin Derivatives in Comparison with Those of Marketed Compounds against <i>Pneumocystis carinii</i> Isolated from RatsPablo Avilés, Domingo Gargallo‐Viola, El Moukhtar Aliouat et al.|Antimicrobial Agents and Chemotherapy|2000Cited by 35
Development of Pneumocystosis Animal Models: Corticosteriod‐Treated Wistar Rat; SCID Mouse and Nude Rat.El Moukhtar Aliouat, Domingo Gargallo‐Viola, Antonio Martı́nez et al.|Journal of Eukaryotic Microbiology|1997Cited by 18
Therapeutic Efficacies of GW471552 and GW471558, Two New Azasordarin Derivatives, against Pneumocystosis in Two Immunosuppressed-Rat ModelsElena Jiménez, Domingo Gargallo‐Viola, Antonio Martı́nez et al.|Antimicrobial Agents and Chemotherapy|2002Cited by 9
Cultured Rat and Purified Human Pneumocystis carinii Stimulate Intra‐but not Extracellular Free Radical Production in Human NeutrophilsTrine Hammer Jensen, Niels Obel, El Moukhtar Aliouat et al.|Journal of Eukaryotic Microbiology|1998Cited by 6